Icotinib plus osimertinib overcome epidermal growth factor receptor 19del/T790 M/C797S/V834L quadruplet resistance mutation in a patient with non-small cell lung cancer

Detalles Bibliográficos
Autores principales: Zhu, Chao, You, Yun-Hong, Nie, Ke-Ke, Ji, You-Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595879/
https://www.ncbi.nlm.nih.gov/pubmed/31033571
http://dx.doi.org/10.1097/CM9.0000000000000196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595879/
https://www.ncbi.nlm.nih.gov/pubmed/31033571
http://dx.doi.org/10.1097/CM9.0000000000000196

Ejemplares similares